| Filed On | Filing |
|---|---|
| 18 Apr 2022 | FORM 15-12B |
| 08 Apr 2022 | EFFECT |
| 08 Apr 2022 | EFFECT |
| 07 Apr 2022 | AMENDMENT NO. 4 TO SCHEDULE 13D |
| 07 Apr 2022 |
Form 4: Warburg Pincus & Co., Director and 9 others
Returned 33,874,965 shares to the issuer ($102M) |
| 07 Apr 2022 |
Form 4: Warburg Pincus & Co., Director and 1 other
Returned 33,874,965 shares to the issuer ($102M) |
| 07 Apr 2022 |
Form 4: Shulman Steven J, Former Director
Returned 1,112,291 shares to the issuer ($3.34M) |
| 07 Apr 2022 |
Form 4: Mikula David, Chief Operating Officer
Returned 496,576 shares to the issuer ($1.49M) |
| 07 Apr 2022 |
Form 4: McGeorge Anne, Former Director
Returned 58,387 shares to the issuer ($175K) |
| 07 Apr 2022 |
Form 4: Kronfol Amr, Former Director
Returned 101,325 shares to the issuer ($304K) · Disposed of 29,437 Stock Options (Disposition to Issuer) |
| 07 Apr 2022 |
Form 4: Kim Eunice, General Counsel
Returned 22,168 shares to the issuer ($66.5K) |
| 07 Apr 2022 |
Form 4: Hallock Robert Jason, Chief Medical Officer
Returned 15,677 shares to the issuer ($47K) |
| 07 Apr 2022 |
Form 4: Greskoviak Joseph P, Former Director
Returned 79,185 shares to the issuer ($238K) |
| 07 Apr 2022 |
Form 4: Gallagher Christopher M., Chief Executive Officer
Disposed of 3,717,922 shares (Other Transaction) |
| 07 Apr 2022 | Form 4: Fletcher David R., Former Interim CFO |
| 07 Apr 2022 |
Form 4: Chisley Gyasi C., Former Director
Returned 44,150 shares to the issuer ($132K) |
| 07 Apr 2022 |
Form 4: Carella Thomas J., Former Director
Returned 90,591 shares to the issuer ($272K) · Disposed of 40,476 Stock Options (Disposition to Issuer) |
| 07 Apr 2022 |
Form 4: Byrne Barbara Peterson, Former Director
Returned 58,387 shares to the issuer ($175K) |
| 06 Apr 2022 | 8-K: Termination of a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +6 more |
| 06 Apr 2022 | POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1 |
Loading...
